Cargando…
Clustering of Chromatin Remodeling Enzymes Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Pancreatic Cancer
In recent years, translational research and pharmacological targeting of epigenetic modifications have become the focus of personalized therapy for patients with pancreatic cancer. Preclinical and clinical trials targeting post-translational modifications have been evaluated as monotherapy or in com...
Autores principales: | Wang, Hui-Ching, Shih, Hsiang-Yao, Wu, Chun-Chieh, Chen, Li-Tzong, Luo, Chi-Wen, Liu, Yi-Chang, Du, Jeng-Shiun, Huang, Min-Chin, Su, Yung-Yeh, Chen, Huan-Da, Hsiao, Hui-Hua, Moi, Sin-Hua, Pan, Mei-Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515693/ https://www.ncbi.nlm.nih.gov/pubmed/36185333 http://dx.doi.org/10.7150/ijms.73800 |
Ejemplares similares
-
Chromatin Remodeling Enzyme Cluster Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Breast Cancer
por: Kuo, Chia-Yu, et al.
Publicado: (2023) -
Effect of Tumor Microenvironment and Angiogenesis on Clinical Outcomes of Primary Central Nervous System Lymphoma
por: Wang, Hui-Ching, et al.
Publicado: (2021) -
The role of the genomic mutation signature and tumor mutation burden on relapse risk prediction in head and neck squamous cell carcinoma after concurrent chemoradiotherapy
por: Wang, Hui-Ching, et al.
Publicado: (2023) -
Deciphering the Functions of Telomerase Reverse Transcriptase in Head and Neck Cancer
por: Yeh, Tsung-Jang, et al.
Publicado: (2023) -
Progression Risk Score Estimation Based on Immunostaining Data in Oral Cancer Using Unsupervised Hierarchical Clustering Analysis: A Retrospective Study in Taiwan
por: Wang, Hui-Ching, et al.
Publicado: (2021)